shock in cardiac infarction is said to be 15%, and the mortality 88% (Epstein & Relman, 1949) . The true mortality is probably nearer to 100% because authors may have included cases of syncope, or of hypotension secondary to a dysrhythmia.
It is worthwhile to treat the hypotension because it predisposes to metabolic acidosis, dangerous dysrhythmia and renal failure; reduces the collateral blood flow to the ischaemic area (Estes et al., 1966) ; reduces the contractility of the myocardium supplied by narrowed coronary vessels (Hellerstein, Brofman & Caskey, 1962) ; and increases the systolic ballooning of the infarcted area (Corday, Bergman & Kruger, 1949) . Therapeutic optimism is encouraged by the observation that the syndrome is commoner in branch occlusions of a coronary artery than in mainstem obstruction (Kurland, Weingarten & Pitt, 1965) , and by the surprisingly rapid and complete recovery of successfully treated patients (Nixon, Ikram & Morton, 1966) .
The treatment has been approached in various ways, by transfusion, by vasoconstrictive drugs, and by inotropic agents. Transfusion passed out of favour when blood volume measurements failed to show deficits, and vasoconstriction was said to be beneficial even though intense vasoconstriction is the most striking physical sign. In our hands the vasoconstrictive drugs have neither saved advanced cases of the syndrome nor have they halted the progression of the metabolic acidosis that indicates the failure of the circulation. If we ever encounter cases of the syndrome where the heart function is adequate, and where vasodilatation is responsible for the hypotension, we shall be prepared to consider the use of vasoconstrictors ! Vasoconstrictive drugs with an inotropic action have yet to prove their value in cardiogenic shock.
Their greatest effect may be in the patients who are syncopal from sedative drugs that encourage the pooling of blood in the patient nursed head up. Often it is difficult to wean patients off these drugs, and infusion is required before their administration can be stopped (Botticelli, Tsagaris & Lange, 1965) .
The authors' experience suggests that infusion alone may be adequate treatment (Nixon et al., 1966) .
In the authors' series of cases with advanced signs and raised central venous pressure, the patients were nursed supine and given oxygen to breathe. Five per cent dextrose was given intravenously by drip in doses of 50-200 ml at a time. The rate of infusion was controlled by observation of the central venous pressure, the arterial pressure, the urine flow, and the clinical appearance of the peripheral circulation. It was not difficult to resuscitate each patient by using the lowest rate of infusion that improved the arterial pressure and the peripheral circulation, and restored the urine flow. Pulmonary' oedema created neither a clinical nor a therapeutic problem, although transitory early signs may have appeared on the radiographs.
Each dose of the solution raised the arterial pressure and also the venous pressure. The latter was allowed to subside towards its original level before the next dose was given. The Fig. 1 ). In 16 min the CVP fell to 12 cm, and further doses of 100-200 ml 5% dextrose were given. The arterial pressure reached a peak of 150/80 (9.45 p.m., Fig. 1) , the heart rate increased; and the change in the shape of the arterial pressure pulse was consistent with a marked increase in the stroke-volume.
Each successive dose of the dextrose solution raised the venous pressure by a smaller amount and for a shorter period until, at 1.14 a.m., 5 hr after the treatment began, 200 ml were infused in 2 min without affecting the CVP. The arterial pressure rose from 80/44 to 110/60 (Fig. 2) . The raising of the arterial pressure with the treatment was accompanied by other signs of improvement. The first was recovery of mental clarity and calm after I hr of transfusion. After 2 hr the urine flowed, and the ECG current of injury diminished. After 4 hr the peripheral circulation seemed normal, and the atrial fibrillation reverted to sinus rhythm (12.38 a.m., Fig. 1) .
By 12.00 noon the day after admission he looked well, and took an alert interest in his surroundings. The blood pressure was stable at 140/80 without transfusion and the CVP was 7 cm. The transfusion was stopped, a total of 4155 ml having been given in 16 hr, during which 943 ml urine were passed.
Four days later he was active in bed; blood pressure 160/85 and CVP 2 cm. Now he has returned to normal activity and is free from heart failure.
It may be considered that this patient, and the others, recovered spontaneously despite the massive infusion; but it is our belief that he was soon to die, and that the infusion resuscitated him.
Another patient was similarly resuscitated but died suddenly during convalescence. Two others failed to respond to the infusion and neither norepinephrine nor epinephrine had any clinically detectable effect upon the circulation. Autopsy revealed severe myocardial damage from previous infarctions.
It has been suggested that the presence of congestive heart failure in cardiogenic shock indicates a 'limited reserve of the circulatory system', and that intravenous infusion may be injudicious and dangerous, 'overdilating' the heart, further reducing the cardiac output and aggravating the shock (Berman & Akman, 1952 ). In the patient described here the central venous pressure was abnormally high (7 cmH2O) at the start of the treatment, and yet the restoration of the blood pressure, peripheral circulation and urine flow, and his recovery, suggest that the transfusion was beneficial. This raises the question as to whether the elevation of the venous pressure really was a sign of congestive heart failure or whether it indicated some other phenomenon. We suggest that it was a sign of constriction of the venous system, the evidence being the great increase in the venous pressure, from 7 to 28 cmH2O, when 200 ml 5% dextrose first were added to the circulating blood volume. This contrasts with the response at a later stage, after the circulation had improved with the infusion of 2380 ml 5% dextrose, when a dose of 200 ml was absorbed without altering the central venous pressure, presumably because the venous constriction had disappeared.
The explanation of the beneficial effect of infusion may lie in the experimental observations of John Ross, Jr (1966, personal communication) . He has shown that the recently injured heart requires distension before its output can be restored to maintain the pre-infarct level of arterial pressure. We suggest that infusion resuscitated our cases by distending the heart to the point at which its output was adequate for the maintenance of life. Clinically there are many similarities between haemorrhagic and cardiogenic shock. In the former, the important disturbance is a deficiency of the effective blood volume. In our cases of recoverable cardiogenic shock, the important disturbance may be a sudden deficiency of the normal blood volume in relation to the needs of the newly-injured heart. Ectopic activity was abolished or minimized under treatment with infusion. One reason for this may be an improvement in the coronary circulation consequent upon the volume-expanding effect of the infused solution. Another reason may be the potassium-shifting or biochemical effect of the infused dextrose (Sodi-Pallares, 1961; Mitra, 1965 
